Interstitial cystitis/bladder pain syndrome (IC/BPS) is a heterogeneous condition with diverse phenotypes and variable treatment response. Recent advances in urothelial biology, afferent signaling, urinary biomarkers, and artificial intelligence provide new opportunities for improving diagnostic accuracy and guiding mechanism-based therapy. This workshop integrates basic science, international clinical evidence, biomarker-guided precision diagnostics, and multimodal treatment strategies. Through expert-led presentations and case-based discussions, participants will gain practical tools to classify IC/BPS phenotypes, interpret biomarker panels, and apply individualized treatment algorithms in clinical practice.

Learning Objectives

• Distinguish IC/BPS phenotypes using clinical, cystoscopic, imaging, and biomarker data.
• Understand key mechanisms of urothelial dysfunction and sensory hypersensitivity that drive symptoms.
• Apply AI mechanism-based and biomarker-guided treatment strategies in real-world IC/BPS management.